Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Center for Cell-Based Therapy (CEPID/FAPESP), National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Ribeirão Preto, Brazil.
Cancer Res. 2019 Jul 1;79(13):3294-3305. doi: 10.1158/0008-5472.CAN-19-0490. Epub 2019 May 17.
Dysregulation of miRNA expression is associated with multiple diseases, including cancers, in which small RNAs can have either oncogenic or tumor suppressive functions. Here we investigated the potential tumor suppressive function of miR-450a, one of the most significantly downregulated miRNAs in ovarian cancer. RNA-seq analysis of the ovarian cancer cell line A2780 revealed that overexpression of miR-450a suppressed multiple genes involved in the epithelial-to-mesenchymal transition (EMT). Overexpression of miR-450a reduced tumor migration and invasion and increased anoikis in A2780 and SKOV-3 cell lines and reduced tumor growth in an ovarian tumor xenographic model. Combined AGO-PAR-CLIP and RNA-seq analysis identified a panel of potential miR-450a targets, of which many, including TIMMDC1, MT-ND2, ACO2, and ATP5B, regulate energetic metabolism. Following glutamine withdrawal, miR-450a overexpression decreased mitochondrial membrane potential but increased glucose uptake and viability, characteristics of less invasive ovarian cancer cell lines. In summary, we propose that miR-450a acts as a tumor suppressor in ovarian cancer cells by modulating targets associated with glutaminolysis, which leads to decreased production of lipids, amino acids, and nucleic acids, as well as inhibition of signaling pathways associated with EMT. SIGNIFICANCE: miR-450a limits the metastatic potential of ovarian cancer cells by targeting a set of mitochondrial mRNAs to reduce glycolysis and glutaminolysis. http://cancerres.aacrjournals.org/content/canres/79/13/3294/F1.large.jpg.
miRNA 表达失调与多种疾病相关,包括癌症,其中小 RNA 可以具有致癌或肿瘤抑制功能。在这里,我们研究了 miR-450a 的潜在肿瘤抑制功能,miR-450a 是卵巢癌中下调最显著的 miRNA 之一。对卵巢癌细胞系 A2780 的 RNA-seq 分析表明,miR-450a 的过表达抑制了多个涉及上皮间质转化 (EMT) 的基因。miR-450a 的过表达降低了 A2780 和 SKOV-3 细胞系的肿瘤迁移和侵袭能力,并增加了细胞的凋亡,同时在卵巢肿瘤异种移植模型中减少了肿瘤生长。AGO-PAR-CLIP 和 RNA-seq 联合分析确定了一组潜在的 miR-450a 靶标,其中许多靶标,包括 TIMMDC1、MT-ND2、ACO2 和 ATP5B,调节能量代谢。在谷氨酰胺耗尽后,miR-450a 的过表达降低了线粒体膜电位,但增加了葡萄糖摄取和活力,这些都是侵袭性较低的卵巢癌细胞系的特征。总之,我们提出 miR-450a 通过调节与谷氨酰胺分解相关的靶标在卵巢癌细胞中发挥肿瘤抑制作用,这导致脂质、氨基酸和核酸的产生减少,以及 EMT 相关信号通路的抑制。意义:miR-450a 通过靶向一组线粒体 mRNA 来限制卵巢癌细胞的转移潜力,从而减少糖酵解和谷氨酰胺分解。http://cancerres.aacrjournals.org/content/canres/79/13/3294/F1.large.jpg。